FRESENIUS SE+CO.KGAA O.N.
FRESENIUS SE+CO.KGAA O.N./ DE0005785604 /
FRE
2024-08-30 4:00:29 PM
|
Chg.
+0.25
|
Volume |
Bid2024-08-30 |
Ask2024-08-30 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
33.53EUR
|
+0.75%
|
0 Turnover: 0.00 |
-Bid Size: - |
-Ask Size: - |
18.73 bill.EUR |
- |
- |
Business description
Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
Management board & Supervisory board
CEO |
Michael Sen |
Management board |
Sara Hennicken, Pierluigi Antonelli , Robert Möller, Michael Moser |
Supervisory board |
Wolfgang Kirsch, Prof. Dr. D. Michael Albrecht, Stefanie Balling , Bernd Behlert , Michael Diekmann , Grit Genster , Konrad Kölbl , Frauke Lehmann , Prof. Dr. med. Iris Löw-Friedrich , Oscar Romero de Paco , Susanne Zeidler , Dr. Christoph Zindel , Holger Michel |
Company data
Name: |
Fresenius SE & Co. KGaA |
Address: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
Phone: |
+49-6172-608-0 |
Fax: |
- |
E-mail: |
pr-fre@fresenius.com
|
Internet: |
www.fresenius.de |
Industry: |
Healthcare |
Sector: |
Medical Products |
Sub sector: |
Advanced Medical Devices |
End of financial year: |
12-31 |
Free Float: |
56.49% |
IPO date: |
1986-12-18 |
Investor relations
Name: |
Markus Georgi |
IR phone: |
+49-6172-608-2485 |
IR Fax: |
+49-6172-608-2488 |
IR e-mail: |
ir-fre@fresenius.com
|